Non-infectious uveitis of the posterior segment with or without immunomodulatory treatment
Conditions
Interventions
Group 1: Disease courses of patients with non-infectious uveitis of the posterior segment
Sponsors
Universitätsklinikum Bonn
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Male or female subjects who are =18 years of age, on the day of signing informed consent - Ability to consent - Non-infectious intermediate, posterior or panuveitis or retinal vasculitis
Exclusion criteria
Exclusion criteria: - Missing or unwilling to consent - Any prior therapy with DMARDs - Intravitreal therapy with dexamethasone, VEGF-Inhibitors, triamcinolone or sirolimus in the last 6 months - Intravitreal therapy with fluocinolone acetonide or methotrexate in the last 36 months - Intraocular surgery within the last 6 months - Severe opacities of cornea, lens or vitreous that preclude assessment of inflammatory activity of the posterior pole - Conceivable inability to attend regularly at participating centre
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remission of disease and reduction or discontinuation of immunomodulatory treatment without relapse. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient reported outcomes, quality of life (QoL) | — |
Countries
Austria, Belgium, Germany, Netherlands, Spain
Contacts
Public ContactJennifer Dell
Universitäts-Augenklinik Bonn
Outcome results
None listed